Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
A plasma microRNA signature of acute lentiviral infection
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
Impaired Bacillus Calmette–Guérin cellular immune response in HIV-exposed, uninfected infants
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1
IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation
A novel role for Slit2/Robo1 axis in modulating HIV-1 replication in T cells
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy
Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen
Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity
Demographic but not geographic insularity in HIV transmission among young black MSM
Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
Antiretroviral therapy refusal among newly diagnosed HIV-infected adults
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients
Epicardial adipose tissue in HIV-infected patients
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals
Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jirovecii pneumonia
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy